CTSO

CYTOSORBENTS CORP

CTSO·23283X206·US·Common Stock·Healthcare - Medical Devices-13D/G

CTSO (CYTOSORBENTS CORP) is held by 37 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.1M), Neuberger Berman Group LLC ($950,776), BlackRock, Inc. ($443,408). Net institutional sentiment: Mixed.

37
Holders
Avg rating(12 Elite)
$4.1M
Total Value
58% (40)
Fund Consensus
15 buying - 11 selling
CTSOSmart Money Verdict
View all
Held by 37 funds
12 elite
Who's Trading
InsiderMJMARIANI PETER JBuy $44KJun 15, 2026
ActivistAVAVENIR CORP8.3%Feb 13, 2026
ActivistAVAvenue Venture Opportunities Fund, L.P.1.7%May 28, 2025
ActivistThe Vanguard GroupThe Vanguard Group3.1%Apr 30, 2025
ActivistSKSkylands Capital, LLC4.8%Apr 17, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
1.9M$1.1M0.0%-52.50%
38
Increased
1.7M(+3.5%)$950,7760.0%-92.10%
26
Increased
782,992(+1.6%)$443,4080.0%-59.88%
17
Increased
707,262(+17.1%)$400,6210.0%-91.23%
19
Unchanged
499,955$283,1240.0%-40.63%
0
New
313,856$177,6420.0%-52.50%
35
Unchanged
172,649$97,7710.0%-59.14%
0
Unchanged
159,293$90,2080.0%-64.98%
0
Unchanged
130,419$74,2450.0%-87.81%
0
Decreased
115,200(-0.1%)$65,2030.0%-58.68%
0
Decreased
107,751(-0.9%)$61,0200.0%-57.85%
0
Increased
100,720(+0.6%)$57,0380.0%-69.83%
21
Decreased
100,169(-14.0%)$56,7260.0%-45.63%
0
Unchanged
92,540$52,4060.0%-93.87%
0
Unchanged
55,556$31,4610.0%-59.14%
0
Unchanged
48,000$27,1830.0%-65.36%
0
Increased
43,947(+22.2%)$24,8870.0%-58.93%
16
Increased
39,123(+1.1%)$22,1430.0%-58.71%
13
Increased
35,570(+19.8%)$20,1430.0%-42.99%
22
Decreased
29,945(-64.1%)$16,9580.0%-69.11%
0

Showing 1-20 of 40

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used